{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:12:27Z","timestamp":1792725147518,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary immunodeficiency is common among patients with autoimmune cytopenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this study is to retrospectively identify key clinical features and biomarkers of primary immunodeficiency (PID) in pediatric patients with autoimmune cytopenias (AIC) so as to facilitate early diagnosis and targeted therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Electronic medical records at a pediatric tertiary care center were reviewed. We selected 154 patients with both AIC and PID (n=17), or AIC alone (n=137) for inclusion in two cohorts. Immunoglobulin levels, vaccine titers, lymphocyte subsets (T, B and NK cells), autoantibodies, clinical characteristics, and response to treatment were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinical features associated with AIC-PID included splenomegaly, short stature, and recurrent or chronic infections. PID patients were more likely to have autoimmune hemolytic anemia (AIHA) or Evans syndrome than AIC-only patients. The AIC-PID group was also distinguished by low T cells (CD3 and CD8), low immunoglobulins (IgG and IgA), and higher prevalence of autoantibodies to red blood cells, platelets or neutrophils. AIC diagnosis preceded PID diagnosis by 3 years on average, except among those with partial DiGeorge syndrome. AIC-PID patients were more likely to fail first-line treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AIC patients, especially those with Evans syndrome or AIHA, should be evaluated for PID. Lymphocyte subsets and immune globulins serve as a rapid screen for underlying PID. Early detection of patients with comorbid PID and AIC may improve treatment outcomes. Prospective studies are needed to confirm the diagnostic clues identified and to guide targeted therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.649182","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T06:11:55Z","timestamp":1619071915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort"],"prefix":"10.3389","volume":"12","author":[{"given":"Emma","family":"Westermann-Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adelia","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Dasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Amre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryssa","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Betensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Isaac","family":"Hauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Metts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Sriaroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmel","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036053","article-title":"New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children","volume":"96","author":"Aladjidi","year":"2011","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3542","article-title":"Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)","volume":"105","author":"Teachey","year":"2005","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-693689","article-title":"How I treat autoimmune hemolytic anemia","volume":"129","author":"Go","year":"2017","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.04.032","article-title":"Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials","volume":"147","author":"Beck","year":"2005","journal-title":"J Pediatr"},{"key":"B6","article-title":"High prevalence of primary immune deficiencies in children with autoimmune disorders","volume":"29","author":"Barsalou","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.08.010","article-title":"Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans\u2019 syndrome","volume":"125","author":"Savasan","year":"2007","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.08.004","article-title":"Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies","volume":"4","author":"Walter","year":"2016","journal-title":"J Allergy Clin Immunol: Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2010.e13","article-title":"Evans syndrome and antibody deficiency: an atypical presentation of chromosome 22q11.2 deletion syndrome","volume":"2","author":"Colarusso","year":"2010","journal-title":"Pediatr Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2015.1073105","article-title":"Current treatment strategies in autoimmune hemolytic disorders","volume":"8","author":"Barcellini","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13533","article-title":"Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience","volume":"171","author":"Miano","year":"2015","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2015.00065","article-title":"Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome","volume":"3","author":"Rao","year":"2015","journal-title":"Front Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B21","volume-title":"The Harriet Lane handbook : a manual for pediatric house officers","author":"Harriet Lane","year":"2015"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000051","article-title":"Primary immunodeficiencies: novel genes and unusual presentations","volume":"2019","author":"Notarangelo","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)80085-6","article-title":"Recurrent immune cytopenias in two patients with DiGeorge\/velocardiofacial syndrome","volume":"131","author":"DePiero","year":"1997","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20110037","article-title":"Hematological abnormalities and 22q11.2 deletion syndrome","volume":"33","author":"Rosa","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1648-1","article-title":"Refractory autoimmune hemolytic anemia in a patient with DiGeorge syndrome treated successfully with plasma exchange: a case report and review of the literature","volume":"100","author":"Damlaj","year":"2014","journal-title":"Int J Hematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/0880010390158685","article-title":"Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report","volume":"20","author":"Kratz","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jaci.2011.06.043","article-title":"Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome","volume":"128","author":"Tison","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27260","article-title":"Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults","volume":"65","author":"Rotz","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2015.00079","article-title":"Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort","volume":"3","author":"Aladjidi","year":"2015","journal-title":"Front Pediatr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000897","article-title":"Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children","volume":"39","author":"Mantadakis","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21501","article-title":"Evans syndrome and idiopathic thrombocytopenic purpura in families: Consider autoimmune lymphoproliferative disease","volume":"50","author":"Rischewski","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-593202","article-title":"Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency","volume":"125","author":"Stepensky","year":"2015","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/1744666X.2020.1745063","article-title":"Revisiting the complement system in systemic lupus erythematosus","volume":"16","author":"Sharma","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","article-title":"Monogenic lupus: it\u2019s all new","volume":"49","author":"Costa-Reis","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jcm9030712","article-title":"New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond","volume":"9","author":"Demirkaya","year":"2020","journal-title":"J Clin Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.38008","article-title":"Protein kinase cdelta deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation","volume":"65","author":"Belot","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.103920","article-title":"Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing","volume":"63","author":"Batlle-Maso","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","article-title":"The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects","volume":"137","author":"Grimbacher","year":"2016","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.649182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T06:11:58Z","timestamp":1619071918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.649182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2021.649182"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.649182","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"article-number":"649182"}}